Panacea Life Sciences and Benivita Launch Benivita PLSH to Expand Virtual Health Benefits

Reuters
2025/11/18
<a href="https://laohu8.com/S/PLSH">Panacea Life</a> Sciences and Benivita Launch Benivita PLSH to Expand Virtual Health Benefits

Panacea Life Sciences Holdings Inc. has announced the launch of Benivita PLSH, a new joint venture with Benivita Inc., aimed at transforming access to non-insurance benefits, virtual telemedicine services, and wellness programs across the United States. Through this partnership, Panacea Life Sciences Holdings will own 100% of Benivita PLSH, providing initial operating capital and issuing restricted common shares to Benivita Inc. The platform will leverage PLSH's infrastructure, Benivita's expertise in direct and multi-level marketing, and New Benefits Inc.'s leadership in benefit aggregation. Benivita PLSH will offer individuals and families direct access to benefit networks typically reserved for corporate employees, with a focus on transparency, compliance, and affordability, particularly targeting underserved markets such as the U.S. Latino population.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Panacea Life Sciences Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA25471) on November 18, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10